Showing results (201-210 of 760) with videos related to

Sort By:
Pageof 76
Chemical & Pharmaceutical Bulletin|September 12, 1998
Synthesis and muscarinic activity of a series of quinolines and naphthalenes with a 1-azabicyclo[3.3.0]octane moietyT Suzuki, T Usui, M Oka, et al.
Japanese Journal of Pharmacology|June 1, 1979
Differential antagonism of antiavoidance, cataleptic and ptotic effects of neuroleptics by biperidenM Oka, K Yamada, C Kamei, et al.
AJNR. American Journal of Neuroradiology|March 23, 2006
Isolated posterior cerebral artery dissection: report of three casesP Sherman, M Oka, E Aldrich, et al.
Molecular Pharmacology|July 1, 1991
Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cellsK Morita, K Teraoka, M Azuma, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1985
Treatment with danazol of ureteral obstruction caused by endometriosisK Matsuura, N Kawasaki, M Oka, et al.
The American Journal of Physiology|May 1, 1997
Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungsM Muramatsu, D M Rodman, M Oka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1991
Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implicationsT Shinomura, Y Asaoka, M Oka, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1989
Synthesis and antiulcer activity of the metabolites of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline dimaleate (AS-2646), a novel gastric antisecretory and antiulcer agentK Hino, K Kawashima, M Oka, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase CY Asaoka, M Oka, K Yoshida, et al.
Biochemical Pharmacology|August 15, 1989
Myosin light-chain kinase inhibitor, 1-(5-chlornaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine (ML-9), inhibits catecholamine secretion from adrenal chromaffin cells by inhibiting Ca2+ uptake into the cellsA Nakanishi, M Yoshizumi, S Hamano, et al.
Pageof 76